Blog

As one of the psychedelic compounds associated with psilocybe cubensis mushrooms, psilocybin has received a lot of bad press in the past. Currently, it’s banned in most states, and using it even for scientific research can require a lot of paperwork and legal research.

Nevertheless, as it often happens, scientists eventually get their voices heard, and the recent growth in popularity of psilocybin-based treatments has already started to gain momentum. Currently, there are optimistic views that psilocybin might actually become the “drug of the future” for helping to treat advanced mental health conditions such as chronic depression and severe anxiety.

A few recent studies, many using liquid culture spore syringe collections, have shown how effective psilocybin can be in treating depression. Cancer patients were used to show how the drug, even in minute amounts and applied only once, can help alleviate the symptoms of depression in the patients and ensure that they feel much better overall.

Additional studies on the use of specific doses of psilocybin, as well as on microdosing with psilocybe cubensis mushrooms, have also shown remarkable promise in the treatment of stress and anxiety, as well as in helping people develop improved creative thinking and achieve better results with their jobs and careers. While future research is necessary, psilocybin is already showing a lot of promise in being potentially used to craft the medical drugs of the future.